Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Corcept Therapeutics Incorporated
Corcept Therapeutics shares gained 15 percent on over 1.6 million shares traded Friday. Analysts at Piper Jaffray have upgraded the company’s rating from “underweight” to “overweight”, while analysts at Janney Capital initiated coverage on the company with a “buy” rating.
Going forward ... (see research report)
Subscribe to News Feeds